Zacks Investment Research
09 Feb 2026, 15:36 UTC · 35w ago
Castle Biosciences (CSTL) Loses 16.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Verdict
Headline leans bearish. We score CSTL +0.80.
Score contradicts the headline.
- Headline says
Leans bearish
From its wording — no explicit rating
- Expected · CSTL
+0.80strongly bullish





